Gaurav Kapoor sold $4.9M of ACM
CHIEF FINANCIAL OFFICER (PAO) at AECOM. 42,400 shares at an average of $115.34, traded Nov 6, 2024, filed Nov 7, 2024.
Score components
- +22RoleCFO
- +25Trade size$4.9M at market
- +20Share of holdings soldSold 58% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +2.7%, 3m -2.0%, 6m -5.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-026311, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 6, 2024 | SOpen-market sale Common Stock10b5-1 | -42,400 | $115.34 | $4.9M | 31,228 | Nov 7, 2024 |
Related signals
Other insiders at AECOM and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | AECOM | Lara Poloni PRESIDENT | $1.7M 17,533 shares | -11% | |
| 23Weak | AECOM | David Y. Gan CHIEF LEGAL OFFICER | $1.5M 15,502 shares | -27% | |
| 35Weak | AECOM | Troy Rudd CHIEF EXECUTIVE OFFICER | $6.3M 53,097 shares | -100% | |
| 15Weak | AECOM | David Y. Gan CHIEF LEGAL OFFICER | $2.3M 20,898 shares | -34% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.